Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease (SEED-AD)

NCT03821857 Phase 4 RECRUITING

The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.

Details

Lead sponsor	Mayo Clinic
Phase	Phase 4
Status	RECRUITING
Enrolment	614
Start date	2019-06-27
Completion	2030-05

Conditions

• Alzheimer Disease

Interventions

• 18-F-Flortaucipir

Primary outcomes

• 18F-Flortaucipir PET imaging — 1 day
  Cortical 18F-Flortaucipir PET imaging measured once in each participant
• Pittsburgh compound-B PET imaging — 1 day
  Global cortical SUVR measured once in each participant

Countries

United States